Protagenic Total Current Assets vs Non Current Liabilities Total Analysis

PTIX Stock  USD 0.50  0.02  3.85%   
Protagenic Therapeutics financial indicator trend analysis is much more than just breaking down Protagenic Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagenic Therapeutics is a good investment. Please check the relationship between Protagenic Therapeutics Total Current Assets and its Non Current Liabilities Total accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.

Total Current Assets vs Non Current Liabilities Total

Total Current Assets vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Protagenic Therapeutics Total Current Assets account and Non Current Liabilities Total. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Protagenic Therapeutics' Total Current Assets and Non Current Liabilities Total is -0.26. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Protagenic Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagenic Therapeutics' Total Current Assets and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Protagenic Therapeutics are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Current Assets i.e., Protagenic Therapeutics' Total Current Assets and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

-0.26
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Non Current Liabilities Total

Most indicators from Protagenic Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagenic Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.Selling General Administrative is likely to drop to about 1.1 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
 2021 2022 2023 2024 (projected)
Reconciled Depreciation37.030.01.6K1.7K
Interest Income33.2K185.8K303.2K318.4K

Protagenic Therapeutics fundamental ratios Correlations

-0.340.1-0.090.65-0.18-0.33-0.030.22-0.19-0.191.0-0.240.58-0.250.68-0.07-0.110.97-0.24-0.24-0.120.93-0.2-0.270.83
-0.34-0.090.54-0.630.360.76-0.48-0.240.370.37-0.310.83-0.260.87-0.230.790.57-0.350.950.830.57-0.220.38-0.28-0.38
0.1-0.09-0.270.260.64-0.210.250.160.640.640.12-0.440.7-0.4-0.04-0.39-0.270.09-0.05-0.44-0.310.230.64-0.440.07
-0.090.54-0.27-0.81-0.10.38-0.980.03-0.1-0.1-0.110.66-0.290.66-0.220.651.0-0.10.560.661.0-0.14-0.09-0.14-0.15
0.65-0.630.26-0.81-0.03-0.520.720.16-0.04-0.040.66-0.640.59-0.650.53-0.53-0.820.67-0.57-0.64-0.820.63-0.05-0.060.65
-0.180.360.64-0.1-0.030.290.13-0.181.01.0-0.15-0.110.35-0.05-0.11-0.14-0.09-0.180.4-0.11-0.080.11.0-0.12-0.13
-0.330.76-0.210.38-0.520.29-0.31-0.790.310.32-0.310.61-0.310.65-0.090.530.42-0.370.710.610.42-0.070.320.03-0.45
-0.03-0.480.25-0.980.720.13-0.31-0.10.130.14-0.01-0.610.15-0.610.16-0.65-0.98-0.04-0.51-0.61-0.970.040.130.2-0.01
0.22-0.240.160.030.16-0.18-0.79-0.1-0.19-0.210.21-0.150.22-0.18-0.05-0.060.010.3-0.22-0.150.0-0.07-0.21-0.280.37
-0.190.370.64-0.1-0.041.00.310.13-0.191.0-0.16-0.10.33-0.04-0.11-0.14-0.09-0.190.4-0.1-0.070.091.0-0.11-0.16
-0.190.370.64-0.1-0.041.00.320.14-0.211.0-0.15-0.10.32-0.04-0.1-0.14-0.09-0.190.4-0.1-0.070.11.0-0.11-0.18
1.0-0.310.12-0.110.66-0.15-0.31-0.010.21-0.16-0.15-0.220.59-0.220.66-0.04-0.130.97-0.2-0.22-0.140.94-0.16-0.30.83
-0.240.83-0.440.66-0.64-0.110.61-0.61-0.15-0.1-0.1-0.22-0.481.0-0.250.970.67-0.250.861.00.68-0.24-0.1-0.16-0.26
0.58-0.260.7-0.290.590.35-0.310.150.220.330.320.59-0.48-0.460.27-0.31-0.30.63-0.2-0.49-0.330.640.31-0.480.7
-0.250.87-0.40.66-0.65-0.050.65-0.61-0.18-0.04-0.04-0.221.0-0.46-0.250.970.67-0.260.891.00.68-0.23-0.03-0.17-0.28
0.68-0.23-0.04-0.220.53-0.11-0.090.16-0.05-0.11-0.10.66-0.250.27-0.25-0.17-0.210.64-0.26-0.25-0.220.67-0.11-0.070.41
-0.070.79-0.390.65-0.53-0.140.53-0.65-0.06-0.14-0.14-0.040.97-0.310.97-0.170.66-0.060.840.970.67-0.09-0.14-0.26-0.06
-0.110.57-0.271.0-0.82-0.090.42-0.980.01-0.09-0.09-0.130.67-0.30.67-0.210.66-0.120.570.670.99-0.15-0.08-0.15-0.18
0.97-0.350.09-0.10.67-0.18-0.37-0.040.3-0.19-0.190.97-0.250.63-0.260.64-0.06-0.12-0.25-0.25-0.130.89-0.2-0.280.89
-0.240.95-0.050.56-0.570.40.71-0.51-0.220.40.4-0.20.86-0.20.89-0.260.840.57-0.250.860.59-0.10.41-0.25-0.24
-0.240.83-0.440.66-0.64-0.110.61-0.61-0.15-0.1-0.1-0.221.0-0.491.0-0.250.970.67-0.250.860.68-0.24-0.1-0.16-0.27
-0.120.57-0.311.0-0.82-0.080.42-0.970.0-0.07-0.07-0.140.68-0.330.68-0.220.670.99-0.130.590.68-0.16-0.07-0.1-0.18
0.93-0.220.23-0.140.630.1-0.070.04-0.070.090.10.94-0.240.64-0.230.67-0.09-0.150.89-0.1-0.24-0.160.09-0.240.74
-0.20.380.64-0.09-0.051.00.320.13-0.211.01.0-0.16-0.10.31-0.03-0.11-0.14-0.08-0.20.41-0.1-0.070.09-0.11-0.18
-0.27-0.28-0.44-0.14-0.06-0.120.030.2-0.28-0.11-0.11-0.3-0.16-0.48-0.17-0.07-0.26-0.15-0.28-0.25-0.16-0.1-0.24-0.11-0.25
0.83-0.380.07-0.150.65-0.13-0.45-0.010.37-0.16-0.180.83-0.260.7-0.280.41-0.06-0.180.89-0.24-0.27-0.180.74-0.18-0.25
Click cells to compare fundamentals

Protagenic Therapeutics Account Relationship Matchups

Protagenic Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets842.3K879.2K11.1M8.0M4.3M4.1M
Other Current Liab1.2M513.3K520.6K620.1K541.5K514.4K
Total Current Liabilities1.2M655.2K799.5K1.1M655.3K622.5K
Total Stockholder Equity(634.4K)(1.1M)9.9M6.9M3.7M6.1M
Property Plant And Equipment Net611.0296.00.01.8K123.3K117.2K
Net Debt(519.3K)702.7K(222.7K)129.0K(1.3M)(1.4M)
Retained Earnings(15.2M)(17.7M)(22.2M)(25.8M)(30.8M)(32.3M)
Cash798.6K671.1K541.2K215.2K1.3M2.0M
Non Current Assets Total611.0296.00.01.8K123.3K117.2K
Non Currrent Assets Other1.0K611.0296.01.8K(1.0)(0.95)
Cash And Short Term Investments798.6K671.1K10.4M8.0M4.1M4.0M
Liabilities And Stockholders Equity842.3K879.2K11.1M8.0M4.3M4.1M
Non Current Liabilities Total161.052.4K279.4K1.4M318.4K1.0M
Other Current Assets43.4K208.2K688.7K56.9K144.0K136.8K
Other Stockholder Equity14.7M16.7M32.4M33.4M34.6M42.6M
Total Liab1.5M2.0M1.1M1.1M655.3K622.5K
Total Current Assets842.0K879.2K11.1M8.0M4.2M7.2M
Accumulated Other Comprehensive Income(172.4K)(171.6K)(248.3K)(676.9K)(113.5K)(119.2K)
Accounts Payable36.2K141.9K279.0K155.5K113.8K108.1K
Net Tangible Assets(210.9K)(634.4K)(1.1M)9.9M11.4M12.0M
Net Invested Capital(355.0K)224.1K10.3M7.3M3.7M3.5M
Net Working Capital(355.3K)224.1K10.3M6.9M3.5M3.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.